What is Big Think?  

We are Big Idea Hunters…

We live in a time of information abundance, which far too many of us see as information overload. With the sum total of human knowledge, past and present, at our fingertips, we’re faced with a crisis of attention: which ideas should we engage with, and why? Big Think is an evolving roadmap to the best thinking on the planet — the ideas that can help you think flexibly and act decisively in a multivariate world.

A word about Big Ideas and Themes — The architecture of Big Think

Big ideas are lenses for envisioning the future. Every article and video on bigthink.com and on our learning platforms is based on an emerging “big idea” that is significant, widely relevant, and actionable. We’re sifting the noise for the questions and insights that have the power to change all of our lives, for decades to come. For example, reverse-engineering is a big idea in that the concept is increasingly useful across multiple disciplines, from education to nanotechnology.

Themes are the seven broad umbrellas under which we organize the hundreds of big ideas that populate Big Think. They include New World Order, Earth and Beyond, 21st Century Living, Going Mental, Extreme Biology, Power and Influence, and Inventing the Future.

Big Think Features:

12,000+ Expert Videos


Browse videos featuring experts across a wide range of disciplines, from personal health to business leadership to neuroscience.

Watch videos

World Renowned Bloggers


Big Think’s contributors offer expert analysis of the big ideas behind the news.

Go to blogs

Big Think Edge


Big Think’s Edge learning platform for career mentorship and professional development provides engaging and actionable courses delivered by the people who are shaping our future.

Find out more

Questionable Pharmaceutical Research

May 7, 2011, 4:09 AM

What's the Latest Development?

Pharmaceutical drug trials are increasingly taking place abroad, particularly in Eastern Europe and Asia, where it is cheaper to operate and governments require less red tape. During a recent trial for a new heart disease drug manufactured by AstraZeneca Plc, medical patients in Poland and Hungary accounted for more than double the American and Canadian ones. In India, hospitals charge between $1,500 and $2,000 per patient case report during a drug trial where an American hospital would charge $20,000, said former GlaxoSmithKline Plc Chief Executive Jean-Pierre Garnier. Costs are likewise much lower in China, which is set to become the world's second-largest market for new pharmaceutical drugs, behind the U.S. 

What's the Big Idea?

The United State's prescription drug market is the largest in the world and, for pharmaceutical companies, F.D.A. approval often makes the difference between turning a profit or taking a loss on a new treatment. So given that drugs are essentially made for American consumers, is it wise to test them increasingly overseas? Will Westerners react to a medication in the same way as a Chinese population who may have a vastly different lifestyle? And is it ethical for pharmaceutical companies to operate in countries who require less paperwork? Concerns abound about companies who parachute in, test new drugs and then leave with little further concern about the health of the population they benefited from. 


Questionable Pharmaceutical...

Newsletter: Share: